Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 25 |
|---|
Dr. Kelvin A. Moses, PHD, MD is an urologist in Nashville, TN specializing in urology (urinary tract disease). He graduated from Baylor College of Medicine in 2004 and has 22 years of experience. Dr. Kelvin A. Moses, PHD, MD is affiliated with Vanderbilt Health.
Vanderbilt Health
Adrenalectomy (Adrenal Surgery)
Adrenalectomy is a surgical procedure to remove the adrenal glands, which lie above each kidney. The adrenal glands are responsible for producing hormones that are necessary for bodily functions, such as the regulation of blood pressure and metabolism. If the adrenal glands overproduce certain hormones, or if a tumor grows on them, removal of the glands is a treatment option.
Adrenal surgery can be open or laparoscopic. Laparoscopic adrenalectomy is a minimally invasive procedure that inserts a thin tube with a camera (laparoscope) through several small incisions on the abdomen. The surgeon uses the laparoscope to guide the procedure and is able to access and remove adrenal glands through the small incisions. Laparoscopic adrenal surgery lasts approximately 1-2 hours.
Laparoscopic adrenalectomy is associated with shorter recovery periods, reduced risk of infection, and smaller scars. Although these factors may be desirable, the location of the tumor, its size, and the severity of the condition may require that an individual instead undergo open surgery. An open adrenalectomy is typically done for larger adrenal tumors and requires a single, large incision on the abdomen. Open adrenal surgery takes around 2-4 hours.
Following the operation, patients will remain in the hospital for 1-2 days for a laparoscopic adrenalectomy or 3-5 days for an open adrenalectomy. Patients will likely have a liquid diet immediately after their surgery, but should be able to return to solid foods after a day. If both of the glands are removed, patients will be given drug therapy to replace the hormones they produced.
Radical Prostatectomy
Prostate cancer is uncommon in men under 40, but the risk of getting the disease significantly increases after the age of 50. If doctors suspect their patients have prostate cancer based on a physical exam or blood test results, he or she may recommend a biopsy. This diagnostic procedure collects tiny samples of tissue from the prostate, typically with the use of a special needle. The samples are then examined in a laboratory to determine whether any abnormal cells are present. Biopsies of the prostate are most often done transrectally, or through the rectum.
If a biopsy shows the presence of prostate cancer, doctors will discuss available options, such as watchful waiting, radiation therapy, hormone therapy, chemotherapy, and surgery. Together, the doctor and patient will develop a treatment plan that best fits the patients' condition. If a doctor recommends surgery, the patient will likely have a radical prostatectomy. There are three ways this prostate removal procedure can be performed:
While incisions for the laparoscopic and robotic approaches will always be on the lower abdomen, there are two possible incision locations for the open procedure. More commonly, the cut will start just below the belly button and end at the pubic bone. The other possible but less frequently used incision location is the area between the base of the scrotum and anus. After the cut is made, the surgeon will separate the prostate from the tissues surrounding it. Extra care will be taken to cause as little injury as possible to the blood vessels and nerves. Patients will wake up from surgery with a small pouch that drains fluids from the belly and a long tube that drains urine from the bladder.
Radical prostatectomy is recommended for cancer that is contained within the prostate. If cancer has spread to other parts of the body, non-surgical treatments like chemotherapy, radiation therapy, or hormone therapy may be more appropriate.
The average hospital stay is one day for a laparoscopic or robotic radical prostatectomy, and one to three days for an open radical prostatectomy. Patients are advised to stay in bed until the morning following the operation. Strenuous activities like running and heavy lifting must be avoided for four to six weeks. Although radical prostatectomy aims to remove all of the cancer cells, patients will still need to see their doctor regularly after surgery to make sure that the cancer does not return.
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2012, Dr. Kelvin A. Moses, PHD, MD performed more foreign body removal procedures for Medicare patients than 75% of providers in related specialties within Tennessee.
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 25 |
|---|
The top procedures that Dr. Kelvin A. Moses, PHD, MD treated as an urologist in Nashville, TN during 2013 were minimally invasive procedures and urologic procedures.
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 90 |
|---|---|
| minimally invasive procedures | 34 |
| urologic procedures | 34 |
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Male | 63 |
|---|---|
| Female | 24 |
| Non-Hispanic White | 51 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 34 |
|---|---|
| From 75 to 84 | 30 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 47 |
| Stroke | 0 |
| Ischemic Heart Disease | 36 |
| Depression | 17 |
| Chronic Kidney Disease | 57 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 25 |
| Chronic Obstructive Pulmonary Disease | 30 |
| Diabetes | 47 |
| Dementia | 0 |
| Cancer | 28 |
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 42 |
|---|
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Non-Hispanic White | 0 |
|---|---|
| Black | 21 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 13 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 15 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 46 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 46 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 46 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 50 |
|---|
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Non-Hispanic White | 58 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 40 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 42 |
| Hypertension | 73 |
|---|---|
| High Cholesterol | 54 |
| Stroke | 0 |
| Ischemic Heart Disease | 37 |
| Depression | 25 |
| Chronic Kidney Disease | 40 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 37 |
| Dementia | 0 |
| Cancer | 54 |
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 39 |
|---|
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| From 65 to 74 | 26 |
|---|---|
| From 75 to 84 | 16 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 68 |
|---|---|
| High Cholesterol | 53 |
| Stroke | 0 |
| Ischemic Heart Disease | 42 |
| Depression | 0 |
| Chronic Kidney Disease | 42 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 40 |
| Dementia | 0 |
| Cancer | 75 |
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 220 |
|---|
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Non-Hispanic White | 84 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 71 |
|---|---|
| From 75 to 84 | 33 |
| 85 and over | 13 |
| Less than 65 | 20 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 41 |
| Stroke | 0 |
| Ischemic Heart Disease | 37 |
| Depression | 14 |
| Chronic Kidney Disease | 36 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 17 |
| Chronic Obstructive Pulmonary Disease | 9 |
| Diabetes | 38 |
| Dementia | 0 |
| Cancer | 62 |
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 307 |
|---|
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Male | 154 |
|---|---|
| Female | 36 |
| Non-Hispanic White | 140 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 93 |
|---|---|
| From 75 to 84 | 60 |
| 85 and over | 13 |
| Less than 65 | 24 |
| Hypertension | 72 |
|---|---|
| High Cholesterol | 48 |
| Stroke | 0 |
| Ischemic Heart Disease | 41 |
| Depression | 19 |
| Chronic Kidney Disease | 53 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 11 |
| Heart Failure | 21 |
| Chronic Obstructive Pulmonary Disease | 14 |
| Diabetes | 32 |
| Dementia | 6 |
| Cancer | 55 |
The top procedures that Dr. Kelvin A. Moses, PHD, MD treated as an urologist in Nashville, TN during 2019 were minimally invasive procedures and urologic procedures.
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 384 |
|---|---|
| minimally invasive procedures | 42 |
| urologic procedures | 42 |
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Male | 207 |
|---|---|
| Female | 58 |
| Non-Hispanic White | 220 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 120 |
|---|---|
| From 75 to 84 | 104 |
| 85 and over | 18 |
| Less than 65 | 23 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 58 |
| Stroke | 6 |
| Ischemic Heart Disease | 45 |
| Depression | 17 |
| Chronic Kidney Disease | 58 |
| Asthma | 5 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 13 |
| Heart Failure | 19 |
| Chronic Obstructive Pulmonary Disease | 15 |
| Diabetes | 36 |
| Dementia | 9 |
| Cancer | 47 |
The top procedures that Dr. Kelvin A. Moses, PHD, MD treated as an urologist in Nashville, TN during 2020 were minimally invasive procedures and urologic procedures.
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| doctor visit | 200 |
|---|---|
| minimally invasive procedures | 23 |
| urologic procedures | 23 |
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Male | 151 |
|---|---|
| Female | 32 |
| Non-Hispanic White | 154 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 93 |
|---|---|
| From 75 to 84 | 59 |
| 85 and over | 14 |
| Less than 65 | 17 |
| Hypertension | 74 |
|---|---|
| High Cholesterol | 57 |
| Stroke | 0 |
| Ischemic Heart Disease | 40 |
| Depression | 20 |
| Chronic Kidney Disease | 55 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 11 |
| Heart Failure | 20 |
| Chronic Obstructive Pulmonary Disease | 12 |
| Diabetes | 38 |
| Dementia | 10 |
| Cancer | 54 |
The top procedures that Dr. Kelvin A. Moses, PHD, MD treated as an urologist in Nashville, TN during 2021 were urologic procedures, minimally invasive procedures, foreign body removal and open surgery.
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| abdominal surgery | 11 |
|---|---|
| doctor visit | 227 |
| foreign body removal | 18 |
| minimally invasive procedures | 33 |
| open surgery | 11 |
| urologic procedures | 44 |
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Male | 165 |
|---|---|
| Female | 41 |
| Non-Hispanic White | 169 |
|---|---|
| Black | 24 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 102 |
|---|---|
| From 75 to 84 | 61 |
| 85 and over | 14 |
| Less than 65 | 29 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 60 |
| Stroke | 0 |
| Ischemic Heart Disease | 43 |
| Depression | 18 |
| Chronic Kidney Disease | 63 |
| Asthma | 6 |
| Osteoperosis | 5 |
| Atrial Fibrilation | 13 |
| Heart Failure | 21 |
| Chronic Obstructive Pulmonary Disease | 13 |
| Diabetes | 39 |
| Dementia | 10 |
| Cancer | 50 |
The top procedures that Dr. Kelvin A. Moses, PHD, MD treated as an urologist in Nashville, TN during 2022 were urologic procedures, minimally invasive procedures, foreign body removal and open surgery.
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
| abdominal surgery | 11 |
|---|---|
| doctor visit | 283 |
| foreign body removal | 25 |
| minimally invasive procedures | 25 |
| open surgery | 11 |
| urologic procedures | 36 |
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Male | 170 |
|---|---|
| Female | 57 |
| Non-Hispanic White | 179 |
|---|---|
| Black | 34 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 104 |
|---|---|
| From 75 to 84 | 76 |
| 85 and over | 13 |
| Less than 65 | 34 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 5 |
| Ischemic Heart Disease | 34 |
| Depression | 25 |
| Chronic Kidney Disease | 45 |
| Asthma | 13 |
| Osteoperosis | 6 |
| Atrial Fibrilation | 22 |
| Heart Failure | 23 |
| Chronic Obstructive Pulmonary Disease | 17 |
| Diabetes | 39 |
| Dementia | 5 |
| Cancer | 72 |
Volume of procedures performed by Dr. Kelvin A. Moses, PHD, MD for Medicare patients.
The highest averages for the top procedures that Dr. Kelvin A. Moses, PHD, MD treated as an urologist in Nashville, TN were urologic procedures, minimally invasive procedures, foreign body removal and open surgery.
| abdominal surgery | 11 |
|---|---|
| doctor visit | 169 |
| foreign body removal | 21 |
| minimally invasive procedures | 31 |
| open surgery | 11 |
| urologic procedures | 35 |
Information about Medicare patients treated by Dr. Kelvin A. Moses, PHD, MD.
| Male | 82 |
|---|---|
| Female | 22 |
| Black / African American | 7 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 95 |
| Native American / Alaskan Native | 0 |
| Hispanic | 0 |
| Other | 0 |
| 75 to 84 | 39 |
|---|---|
| 85 and over | 7 |
| Less than 65 | 18 |
| 65 to 74 | 63 |
The highest averages of the most common conditions of Medicare patients that Dr. Kelvin A. Moses, PHD, MD treated were hypertension, high cholesterol, cancer and chronic kidney disease.
| Hypertension | 67 |
|---|---|
| High Cholesterol | 49 |
| Stroke | 1 |
| Ischemic Heart Disease | 32 |
| Depression | 14 |
| Chronic Kidney Disease | 45 |
| Asthma | 2 |
| Osteoporosis | 1 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 35 |
| Atrial Fibrillation | 6 |
| Dementia | 3 |
| Cancer | 45 |
Dr. Kelvin A. Moses, PHD, MD graduated from Baylor College of Medicine in 2004. He completed residency at Emory University Affiliated Hospitals. He is certified by the Urology - American Board of Urology and has a state license in Georgia.
Medical School: Baylor College of Medicine (2004)
Residency: Emory University Affiliated Hospitals (2010)
Board Certification: Urology - American Board of Urology (2015)
Licensed In: Georgia
Dr. Kelvin A. Moses, PHD, MD is associated with these hospitals and organizations:
Dr. Kelvin A. Moses, PHD, MD has an exceptional overall rating with an average of 4.9 out of 5 stars based on 346 ratings. We collect ratings and reviews of Dr. Kelvin A. Moses, PHD, MD from all over the web to help you find the right in Nashville, TN.
These charts describe general payments received by Dr. Kelvin A. Moses, PHD, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Astellas Pharma US Inc |
$34,743
XTANDI $34,107 |
Vesicare $31 |
$605 |
|||
|---|---|---|---|---|---|---|
| Dendreon Pharmaceuticals LLC |
$22,087
PROVENGE $22,087 |
|||||
| Pfizer Inc. |
$8,217
ORGOVYX $2,960 |
XTANDI $8 |
$5,249 |
|||
| Boston Scientific Corporation |
$5,409
RF 3000 $4,032 |
Therapies $1,192 |
KIDNEY STONE DISEASE $100 |
Rezum $47 |
Lithotripsy $38 |
|
| Bayer HealthCare Pharmaceuticals Inc. |
$2,867
Nubeqa $2,356 |
Xofigo $511 |
||||
| Other |
$10,164
ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization $2,109 |
XTANDI $1,306 |
Cysview $950 |
PROVENGE $550 |
Erleada $367 |
Other $4,882 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,428 |
|---|---|
| Consulting Fee | $25,080 |
| Travel and Lodging | $7,915 |
| Food and Beverage | $7,912 |
| Honoraria | $2,960 |
| Other | $192 |
Dr. Kelvin A. Moses, PHD, MD has received 78 research payments totaling $313,226.
Dr. Kelvin Moses is a Nashville, TN physician who specializes in urology (urinary tract disease). His areas of expertise include adrenalectomy (adrenal surgery), robotic partial nephrectomy, and radical nephrectomy. He has a 5.0 out of 5 star average patient rating. Dr. Moses obtained his medical school training at Baylor College of Medicine and performed his residency at a hospital affiliated with Emory University. He speaks Spanish. Dr. Moses is professionally affiliated with Vanderbilt University Medical Center (VUMC).